Prevalencia de lesiones óseas metastásicas diagnosticadas mediante Gammagrafía MDP en pacientes con cáncer de mama confirmado en el Instituto del Cáncer Solca, Cuenca durante el periodo Enero 2020 - Diciembre 2021

Abstract

Breast cancer is one of the most common neoplasms among the female population, mainly in the population over 40 years of age. It is characterized by excessive and excessive growth of cellular structures which causes abnormalities in the breast structure of variable size which can evolve in such a way to cause the appearance of metastatic spread to different areas of the body of the affected person leading to the aggravation of symptoms until subsequent death if not treated properly. Metastatic bone lesions are prone to be a secondary condition in breast carcinoma as well as in other types of cancer only changing its origin depending on the carcinoma in question. Viable tests for detection and assessment are conventional radiology studies, computed tomography, magnetic resonance imaging and bone scintigraphy due to their ability to characterize the lesion either inside or outside the bone. Its treatment possibilities are mainly based on radiotherapy and surgery. The former makes it possible to identify the existence of a foreseeable risk of fracture due to the previously diagnosed lesion. On the other hand, surgery is applied in circumstances of poor or null response to radiotherapy or in situations of high possibility of fracture. This condition constitutes an important public health problem in Ecuador and on a global scale due to its high mortality rate and the disabilities generated to its carrier.